Bolt Biotherapeutics Inc (BOLT)
0.8322
0.00 (0.00%)
USD |
NASDAQ |
May 16, 15:00
Bolt Biotherapeutics Profit Margin (Quarterly): -857.0% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -857.0% |
| September 30, 2023 | -643.1% |
| June 30, 2023 | -1.26K% |
| March 31, 2023 | -929.9% |
| December 31, 2022 | -1.42K% |
| September 30, 2022 | -1.03K% |
| June 30, 2022 | -1.63K% |
| March 31, 2022 | -2.91K% |
| December 31, 2021 | -5.35K% |
| Date | Value |
|---|---|
| September 30, 2021 | -3.11K% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -16.51K% |
| March 31, 2020 | -5.26K% |
| December 31, 2019 | -14.40K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.51K%
Minimum
Jun 2020
-643.1%
Maximum
Sep 2023
-4.25K%
Average
-1.63K%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.57% |
| Return on Assets | -36.05% |
| Return on Invested Capital | -48.57% |
| Operating Margin (Quarterly) | -946.2% |
| Return on Net Operating Assets | -263.4% |